NPY2R

Chr 4

neuropeptide Y receptor Y2

Also known as: NPY2-R

Enables G-protein alpha-subunit binding activity and peptide YY receptor activity. Involved in adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; cardiac left ventricle morphogenesis; and outflow tract morphogenesis. Located in cilium and plasma membrane. Implicated in several diseases, including Huntington's disease; alcohol dependence; cocaine dependence; nicotine dependence; and obesity (multiple). Biomarker of peripheral artery disease and temporal lobe epilepsy. [provided by Alliance of Genome Resources, Jun 2026]

ResearchGenerating clinical summary…
0
Active trials
40
Pubs (1 yr)
P/LP submissions
P/LP missense
0.88
LOEUF
Multiple*
Mechanism· predicted
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.88LOEUF
pLI 0.036
Z-score 1.85
OE 0.38 (0.190.88)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.81Z-score
OE missense 0.84 (0.740.95)
178 obs / 211.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.38 (0.190.88)
00.351.4
Missense OE?0.84 (0.740.95)
00.61.4
Synonymous OE?1.18
01.21.6
LoF obs/exp: 4 / 10.5Missense obs/exp: 178 / 211.2Syn Z: -1.28

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

NPY2R · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →